AAAAAA

   
Results: 1-7 |
Results: 7

Authors: LEBRET T GAUDEZ F HERVE JM BARRE P LUGAGNE PM BOTTO H
Citation: T. Lebret et al., LOW-DOSE BCG INSTILLATIONS IN THE TREATMENT OF STAGE T1 GRADE 3 BLADDER-TUMORS - RECURRENCE, PROGRESSION AND SUCCESS, European urology, 34(1), 1998, pp. 67-72

Authors: LEBRET T HERVE JM BARRE P GAUDEZ F LUGAGNE PM BARBAGELATTA M BOTTO H
Citation: T. Lebret et al., URETHRAL RECURRENCE OF TRANSITIONAL-CELL CARCINOMA OF THE BLADDER - PREDICTIVE VALUE OF PREOPERATIVE LATERO-MONTANAL BIOPSIES AND URETHRAL FROZEN-SECTIONS DURING PROSTATOCYSTECTOMY, European urology, 33(2), 1998, pp. 170-174

Authors: LEBRET T BECETTE V BARBAGELATTA M HERVE JM GAUDEZ F BARRE P LUGAGNE PM BOTTO H
Citation: T. Lebret et al., CORRELATION BETWEEN P53 OVER-EXPRESSION AND RESPONSE TO BACILLUS-CALMETTE-GUERIN THERAPY IN A HIGH-RISK SELECT POPULATION OF PATIENTS WITH T1G3 BLADDER-CANCER, The Journal of urology, 159(3), 1998, pp. 788-791

Authors: LUGAGNE PM HERVE JM LEBRET T BARRE P MOLLIER S BOTTO H
Citation: Pm. Lugagne et al., URETEROILEAL IMPLANTATION IN ORTHOTOPIC NEOBLADDER WITH THE LE-DUC-CAMEY MUCOSAL-THROUGH TECHNIQUE - RISK OF STENOSIS AND LONG-TERM FOLLOW-UP, The Journal of urology, 158(3), 1997, pp. 765-767

Authors: SALOMON L LUGAGNE PM HERVE JM BARRE P LEBRET T BOTTO H
Citation: L. Salomon et al., NO EVIDENCE OF METABOLIC DISORDERS 10 TO 22 YEARS AFTER CAMEY TYPE-I ILEAL ENTEROCYSTOPLASTY, The Journal of urology, 157(6), 1997, pp. 2104-2106

Authors: GUILLONNEAU B BALLANGER P LUGAGNE PM VALLA JS VALLANCIEN G
Citation: B. Guillonneau et al., LAPAROSCOPIC VERSUS LUMBOSCOPIC NEPHRECTOMY, European urology, 29(3), 1996, pp. 288-291

Authors: HUONG DLT PAPO T LUGAGNE PM RICHARD F GODEAU P
Citation: Dlt. Huong et al., PROSTATITIS REVEALING WEGENERS GRANULOMATOSIS, Journal of rheumatology, 22(1), 1995, pp. 187-187
Risultati: 1-7 |